Solanum Medical Communications. Fair balance, transparency, good practice, trust and reliability: The cornerstones of "doing the right thing" for patients
Want a Visual Guide to Developing Strategic Publication Plans? Check out this new article in The MAP with a stepwise infographic: https://t.co/ztJ0KrGOaI A Must to View! Thank you to authors: @mjthomp2, @johnpgonzalez, @carolinehalford & Krupa O'Neill. #MedPubs#MedComms#biotech
#OpenAccess (OA) to research published by pharmaceutical companies can improve transparency and foster trust. Being able to benchmark companies is an important step. Proud to be amongst the frontrunners in OA! #PioneeringForPatients#ISMPPAnnual2022
Fake covid vaccines boost the black market for counterfeit medicines https://t.co/d1f5RaV6o3
I guess it was only a matter of time before this started to happen......
Predatory publishers’ latest scam: bootlegged and rebranded papers https://t.co/JWx0TkRkrh
Like with the Hydra, you can chop off some of the tentacles but the beast keeps going!
Henrietta Lacks, Whose Cells Were Taken Without Her Consent, Is Honoured by The WHO. https://t.co/ALH2NLPUPn
Read this NYT article and the book by Rebecca Skloot "The Immortal Life of Henrietta Lacks" if you have ever been involved with oncology or biomedical sciences.
When you most need to understand complex medical literature, #PlainLanguageSummaries can help a lot.
We at @_OpenPharma have published our recommendations for PLS in @CMRO_online to ensure baseline #accessibility and clarity.
Read them here: https://t.co/d51OiF78Bo
Despite significant scientific progress in the understanding of chronic inflammatory diseases, patients continue to face challenges in holistically controlling their #IBD. We listen to patients to better understand ongoing areas of need to inform our research.
Clinical trial transparency and data sharing among biopharmaceutical companies and the role of company size, location and product type: a cross-sectional descriptive analysis @BMJ_Open https://t.co/sLCQ6nXIUM